Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
Doc Wire News,
This article was originally published here Pilot Feasibility Stud. 2022 Apr 21;8(1):87.